FC
FORA Capital Portfolio holdings
AUM
$901M
1-Year Return
36.51%
This Quarter Return
-5.54%
1 Year Return
+36.51%
3 Year Return
+97.39%
5 Year Return
+233.5%
10 Year Return
–
AUM
$986M
AUM Growth
+$112M
(+13%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
14.56%
Top 10 Holdings %
Top 10 Hldgs %
15.13%
Holding
670
New
300
Increased
81
Reduced
103
Closed
186
Top Buys
| 1 |
Cisco
CSCO
|
$17.3M |
| 2 |
Microsoft
MSFT
|
$17.2M |
| 3 |
GE Vernova
GEV
|
$16.6M |
| 4 |
Oracle
ORCL
|
$14.5M |
| 5 |
Walmart
WMT
|
$14.3M |
Top Sells
| 1 |
Netflix
NFLX
|
$13.8M |
| 2 |
Arista Networks
ANET
|
$9.83M |
| 3 |
Qualcomm
QCOM
|
$9.8M |
| 4 |
Constellation Brands
STZ
|
$9.63M |
| 5 |
D.R. Horton
DHI
|
$9.16M |
Sector Composition
| 1 | Technology | 27.71% |
| 2 | Industrials | 13.66% |
| 3 | Financials | 12.36% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Healthcare | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dutch Bros
BROS
$8.38B
| $3.96M | 0.4% |
64,138
+43,552
| +212% | +$2.69M |
|
77
Booz Allen Hamilton
BAH
$12.6B
| $3.93M | 0.4% |
+37,585
| New | +$3.93M |
|
78
Infosys
INFY
$67.9B
| $3.92M | 0.4% |
+214,743
| New | +$3.92M |
|
79
Brinker International
EAT
$7.04B
| $3.89M | 0.39% |
26,095
+20,029
| +330% | +$2.99M |
|
80
Bank of New York Mellon
BK
$73.1B
| $3.81M | 0.39% |
45,468
+40,490
| +813% | +$3.4M |
|
81
Roper Technologies
ROP
$55.8B
| $3.81M | 0.39% |
6,454
-10,135
| -61% | -$5.98M |
|
82
Goldman Sachs
GS
$223B
| $3.73M | 0.38% |
+6,819
| New | +$3.73M |
|
83
Teradyne
TER
$19.1B
| $3.72M | 0.38% |
+45,078
| New | +$3.72M |
|
84
F5
FFIV
$18.1B
| $3.6M | 0.36% |
+13,502
| New | +$3.6M |
|
85
Celanese
CE
$5.34B
| $3.57M | 0.36% |
62,940
-12,805
| -17% | -$727K |
|
86
Canadian Pacific Kansas City
CP
$70.3B
| $3.5M | 0.35% |
49,808
+25,631
| +106% | +$1.8M |
|
87
Apollo Global Management
APO
$75.3B
| $3.47M | 0.35% |
25,376
-65,251
| -72% | -$8.94M |
|
88
Becton Dickinson
BDX
$55.1B
| $3.46M | 0.35% |
+15,097
| New | +$3.46M |
|
89
Regeneron Pharmaceuticals
REGN
$60.8B
| $3.45M | 0.35% |
5,447
+2,894
| +113% | +$1.84M |
|
90
Danaher
DHR
$143B
| $3.45M | 0.35% |
16,847
+8,750
| +108% | +$1.79M |
|
|
ITCI
91
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.45M | 0.35% |
+26,176
| New | +$3.45M |
|
92
Wingstop
WING
$8.65B
| $3.45M | 0.35% |
15,292
+2,622
| +21% | +$591K |
|
93
Novo Nordisk
NVO
$245B
| $3.45M | 0.35% |
49,673
+13,917
| +39% | +$966K |
|
94
Merck
MRK
$212B
| $3.45M | 0.35% |
38,399
+7,461
| +24% | +$670K |
|
95
Biogen
BIIB
$20.6B
| $3.42M | 0.35% |
24,991
+5,505
| +28% | +$753K |
|
96
Emerson Electric
EMR
$74.6B
| $3.39M | 0.34% |
+30,901
| New | +$3.39M |
|
97
Hologic
HOLX
$14.8B
| $3.37M | 0.34% |
54,598
+39,780
| +268% | +$2.46M |
|
98
Omnicom Group
OMC
$15.4B
| $3.29M | 0.33% |
+39,697
| New | +$3.29M |
|
99
Ecolab
ECL
$77.6B
| $3.28M | 0.33% |
+12,955
| New | +$3.28M |
|
100
Entergy
ETR
$39.2B
| $3.28M | 0.33% |
+38,361
| New | +$3.28M |
|